| 7454 | WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | IMD2,THC,WASP | |
| 6504 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | CD150,CDw150,SLAM | |
| 6622 | SNCA | synuclein, alpha (non A4 component of amyloid precursor) | MGC110988,NACP,PARK1,PARK4,PD1 | |
| 3689 | ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | CD18,LAD,LCAMB,LFA-1,MAC-1,MF17,MFI7 | |
| 2870 | GRK6 | G protein-coupled receptor kinase 6 | FLJ32135,GPRK6 | |
| 286 | ANK1 | ankyrin 1, erythrocytic | ANK,SPH1,SPH2 | |
| 3059 | HCLS1 | hematopoietic cell-specific Lyn substrate 1 | CTTNL,HS1 | |
| 640 | BLK | B lymphoid tyrosine kinase | MGC10442 | |
| 79930 | DOK3 | docking protein 3 | FLJ22570,FLJ39939 | |
| 7099 | TLR4 | toll-like receptor 4 | CD284,TOLL,hToll | |
| 2214 | FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD16,CD16a,FCG3,FCGR3,IGFR3 | |
| 3937 | LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | SLP-76,SLP76 | |
| 2212 | FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | CD32,CD32A,CDw32,FCG2,FCGR2,FCGR2A1,FcGR,IGFR2,MGC23887,MGC30032 | |
| 5788 | PTPRC | protein tyrosine phosphatase, receptor type, C | B220,CD45,GP180,LCA,LY5,T200 | |
| 4318 | MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | CLG4B,GELB,MMP-9 | |
| 5450 | POU2AF1 | POU domain, class 2, associating factor 1 | BOB1,OBF-1,OBF1,OCAB | |
| 11184 | MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | HPK1 | |
| 960 | CD44 | CD44 molecule (Indian blood group) | CDW44,CSPG8,ECMR-III,HCELL,IN,LHR,MC56,MDU2,MDU3,MGC10468,MIC4,MUTCH-I,Pgp1 | |
| 6850 | SYK | spleen tyrosine kinase | - | |
| 3635 | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | MGC104855,MGC142140,MGC142142,SHIP,SHIP1,SIP-145,hp51CN | |
| 52 | ACP1 | acid phosphatase 1, soluble | HAAP,MGC111030,MGC3499 | |
| 2534 | FYN | FYN oncogene related to SRC, FGR, YES | MGC45350,SLK,SYN | |